Abbott Laboratories buy JPMorgan Chase & Co.
Start price
20.04.23
/
50%
€101.24
Target price
20.04.24
€111.01
Performance (%)
-0.75%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. The BUY prediction by JPMorgan_Chase___Co_ for Abbott Laboratories closed nearly unchanged. JPMorgan_Chase___Co_ has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. A total of €1.96 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Abbott Laboratories | 6.624% | 6.624% | -27.828% | -17.174% |
| iShares Core DAX® | -1,36 % | -2,33 % | 3,44 % | 53,51 % |
| iShares Nasdaq 100 | -3,70 % | -1,24 % | 33,08 % | 90,97 % |
| iShares Nikkei 225® | -2,51 % | 6,91 % | 60,78 % | 81,10 % |
| iShares S&P 500 | -1,66 % | -0,64 % | 23,47 % | 67,07 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at JPMorgan Chase & Co. from $118.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€80.40
17.04.26
17.04.26
€93.41
17.04.27
17.04.27
2.51%
26.06.26
26.06.26
